Cargando…
The preventive effect of metformin on progression of benign prostate hyperplasia: A nationwide population-based cohort study in Korea
Metformin, a first-line treatment for type 2 diabetes mellitus (T2DM), has recently been recognized for its pleotropic anti-proliferative, anti-cancer, and anti-aging effects. Contrary to the studies characterizing metformin effects in prostate cancer, little is known about these effects in BPH prog...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641083/ https://www.ncbi.nlm.nih.gov/pubmed/31323022 http://dx.doi.org/10.1371/journal.pone.0219394 |